|
|
|
|
FDA Advisory Panel Unanimously Recommends Approval of NAVISTAR THERMOCOOL Catheter for Atrial Fibrillation
Biosense Webster, Inc., a Johnson & Johnson company, today reported the Circulatory System Devices Panel of the U.S.Food and Drug Administration (FDA) unanimously recommended approval of the Companys Pre-Market Approval (PMA)...
|
|
|
Atrial Fibrillation - New atrial fibrillation research reported from University of Kansas
'Percutaneous is a common procedure to treat atrial fibrillation,' scientists in the United States report.'We describe a patient without a urologic history who had immediate pain after this treatment. Computed scan and cystoscopy...
|
|
|
Study Suggests Need for More Aggressive Outpatient Monitoring of Patients' Hearts When Cause of Stroke is Uncl
Nearly One Third of Stroke Patients Leave Hospital With No Explanation for Injury PITTSBURGH, Nov.19 /PRNewswire/ -- In nearly one third of all people who suffer from a stroke, the underlying cause of the injury is not readily evident to...
|
|
|
Study Suggests Need for More Aggressive Outpatient Monitoring of Patients' Hearts When Cause of Stroke is Uncl
Nearly One Third of Stroke Patients Leave Hospital With No Explanation for Injury PITTSBURGH, Nov.19 /PRNewswire/ -- In nearly one third of all people who suffer from a stroke, the underlying cause of the injury is not readily evident to...
|
|
|
Study Suggests Need for More Aggressive Outpatient Monitoring of Patients' Hearts When Cause of Stroke is Uncl
Nearly One Third of Stroke Patients Leave Hospital With No Explanation for Injury PITTSBURGH, Nov.19 /PRNewswire/ -- In nearly one third of all people who suffer from a stroke, the underlying cause of the injury is not readily evident to...
|
|
|
Basic electrocardiography: Recognizing common arrhythmias (Proceedings)
The electrocardiogram (ECG) is a record of the average electrical potential generated in the heart muscle at the body's surface.The electrocardiograph amplifies and filters these small electrical signals and graphs this signal in voltage...
Thomson Veterinary Healthcare Communications:
Nov 20 2008 4:25AM
Matching: atrial arrhythmia
|
Find similar documents
|
|
|
|
Magnetically Steered Irrigated Tip Cardiac Catheter for Treatment of Irregular Heart Rhythms Now Available Thr
6269 live jobs on PharmiWeb.com now NAVISTAR RMT THERMOCOOL combines the safety of power-controlled irrigated tip technology with the control of remote magnetic navigation away from fluoroscopy exposure Diamond Bar, CA (November 18, 2008) -...
|
|
|
ASHG 2008: Human Chromosome 4 Variants Associated With Increased Risk for Atrial Fibrillation
November 17, 2008 (Philadelphia, Pennsylvania) A new genetic study has identified 7 single-nucleotide polymorphisms (SNPs) within a single haplotype on human chromosome 4, which are associated with atrial fibrillation (AF) after...
|
|
|
FDA: No Heart Rhythm Risk From Bone Drugs
No Proof of Atrial Fibrillation Risk From Bisphosphonates Such as Fosamax, Says FDA Nov.12, 2008 -- The FDA says it sees no proof that the bone drugs called bisphosphonates are linked to a heart rhythm problem called atrial...
|
|
|
FDA MedWatch- Bisphosphonates-Update To The Early Communication Issued Regarding Atrial Fibrillation With Bisp
Early Communication about the Ongoing Safety Review of Bisphosphonates Bisphosphonates: Alendronate (Fosamax, Fosamax Plus D), Etidronate (Didronel), Ibandronate (Boniva), Pamidronate (Aredia), Risedronate (Actonel, Actonel W/Calcium),...
|
|
|
High-Normal Thyroid Function and Risk of Atrial Fibrillation
Heeringa J et al.- Authors aimed to investigate the association of high-normal thyroid function with the development of atrial fibrillation in a prospective population-based study in the elderly. Within the normal range of thyroid...
|
|
|
Medtronic Acquires CryoCath Technologies Inc
MINNEAPOLIS--(BUSINESS WIRE)--Nov.13, 2008 - Medtronic, Inc. (NYSE:MDT) announced today that it has been successful in its bid, through an indirect wholly-owned subsidiary, to acquire CryoCath(R) Technologies Inc. (TSX:CYT) at $8.75...
|
|
|
Dronedarone Reduced the Incidence and Duration of Hospitalization in Patients with Atrial Fibrillation
_ Dronedarone Reduced the Incidence and Duration of Hospitalization in Patients with Atrial Fibrillation.
|
|
|
No Link Between Bisphosphonates and Atrial Fibrillation, FDA Says
_ No Link Between Bisphosphonates and Atrial Fibrillation, FDA Says.
Abstracts in Hematology and Oncology:
Nov 14 2008 12:16AM
Matching: atrial fibrillation
|
Find similar documents
|
|
|
|
Research from University of Frankfurt provides new data about atrial fibrillation
- (NewsRx.com) -- According to a study from Frankfurt, Germany, 'The morbidity and mortality associated with atrial fibrillation (AF) are related mainly to ischaemic stroke, and the prevention of thrombo-embolism is an important...
|
|
|
No Link Between Bisphosphonates and Atrial Fibrillation, FDA Says
_ No Link Between Bisphosphonates and Atrial Fibrillation, FDA Says.
|
|
|
Noninvasive Mapping of Human Atrial Fibrillation
_ Noninvasive Mapping of Human Atrial Fibrillation.
|
|
|
Dronedarone (Multaq(R)) Reduced the Incidence and Duration of Hospitalization in Patients With Atrial Fibrilla
NEW ORLEANS, Nov.12 /PRNewswire-AsiaNet/ -- - New Post-Hoc Analysis From Athena Study Showed That Multaq(R) on Top of Standard Therapy Significantly Decreased the Total Number of Hospital Days by 28% in Patients With Atrial ...
|
|
|
New Study Shows Central Blood Pressure Is a Superior Predictor of Development of Atrial Fibrillation
ITASCA, IL -- (MARKET WIRE) -- 11/12/08 -- AtCor Medical (ASX: ACG), the developer and marketer of the SphygmoCor system which measures central blood pressures and arterial stiffness noninvasively, today announced that a new study* funded by...
|
|
|
Device To Treat Atrial Fibrillation Superior: Study
Johnson & Johnson's ablation device outperformed drug therapy for the heart rhythm disorder atrial fibrillation in a study that will be used to seek U.S.regulatory approval for the treatment, J&J said on Tuesday. Patients...
|
|
|
New Study Shows Central Blood Pressure Is a Superior Predictor of Development of Atrial Fibrillation
AtCor Medical (ASX: ACG), the developer and marketer of the SphygmoCor(R) system which measures central blood pressures and arterial stiffness noninvasively, today announced that a new study* funded by the National Institutes of Health (NIH)...
|
|
|
New Study Shows Central Blood Pressure Is a Superior Predictor of Development of Atrial Fibrillation
AtCor Medical (ASX: ACG), the developer and marketer of the SphygmoCor system which measures central blood pressures and arterial stiffness noninvasively, today announced that a new study* funded by the National Institutes of Health (NIH)...
|
|
|
New Study Shows Central Blood Pressure Is a Superior Predictor of Development of Atrial Fibrillation
ITASCA, IL, November 12 / MARKET WIRE/ -- AtCor Medical (ASX: ACG), the developer and marketer of the SphygmoCor system which measures central blood pressures and arterial stiffness noninvasively, today announced that a new study* funded by...
|
|
|
Pulmonary-Vein Ablation Edges Out Refractory Atrial Fibrillation in Heart Failure
ELK GROVE VILLAGE, Ill., Oct.22 -- For atrial fibrillation in heart failure patients, blocking aberrant electrical signals from the pulmonary veins is better than AV-node ablation with biventricular pacing, researchers found.
|
|
|
New Study Shows Central Blood Pressure Is a Superior Predictor of Development of Atrial Fibrillation
ITASCA, IL, November 12 / MARKET WIRE/ -- AtCor Medical (ASX: ACG), the developer and marketer of the SphygmoCor system which measures central blood pressures and arterial stiffness noninvasively, today announced that a new study* funded by...
|
